基于LET的对质子辐射治疗的微剂量对称运动模型的近似估计
Alessio Parisi1, Keith M Furutani1, Tatsuhiko Sato2,3
1Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida, USA.
Medical physics
|August 17, 2024
概括
本研究介绍了一种基于LET的实用微剂量对称运动模型 (MKM) 用于质子疗法,改善了相对生物效率 (RBE) 预测. 新模型与实验数据保持一致,为临床应用提供了有价值的工具.
科学领域:
- 医学物理 医学物理
- 辐射瘤学 辐射瘤学
- 放射生物学的放射生物学
背景情况:
- 在质子疗法中的现象学相对生物有效性 (RBE) 模型,依赖于剂量平均线性能量转移 (LET),由于经验假设,显示出显著的变化.
- 基于理论的模型,如微剂量对称运动模型 (MKM),用于碳离子放射治疗,但在质子疗法规划系统中存在实施挑战.
研究的目的:
- 介绍适用于临床质子放射治疗的微剂量对称动力模型 (MKM) 的实用,基于LET的版本.
- 弥合理论微剂量测量与基于LET的质子疗法的临床应用之间的差距.
主要方法:
- 获得了梅奥诊所佛罗里达州 (MCF) 的MKM对质子辐射的近似,保持了从细胞特征中确定参数等关键特征.
- 使用蒙特卡洛模拟 (PHITS) 来将微剂量计量与对质子的剂量平均值 LET 相对应.
- 在剂量平均的LET和剂量平均的线性能量之间使用全度函数建立了启发式相关性.
主要成果:
- 基于LET的MKM准确地模拟了暴露于质子束的人类和动物细胞系的体外克隆性生存RBE.
- 模型预测与其他评估模型相比,与生物数据达成可比或更高的一致性.
- 灵敏度分析证实了基于LET的MKM结果的稳定性.
结论:
- 开发的基于LET的MKM有效地将MCF MKM的理论优势与基于LET的实际RBE描述相结合.
- 这种模型很容易在质子疗法治疗计划系统中实现,因为它依赖于剂量平均的LET.
- 该研究为质子疗法中RBE评估提供了更准确和临床适用的工具.
相关概念视频
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
95
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
95
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
171
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
171
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
203
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
203
01:18Nonlinear Pharmacokinetics: Michaelis-Menten Equation
865
The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
865
01:20Pharmacokinetic Models: Overview
1.7K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.7K
01:26Pharmacokinetic Models: Comparison and Selection Criterion
262
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
262